AU2022406916A1 - Methods and compositions relating to treatment and prevention of fatty acid deficiencies - Google Patents

Methods and compositions relating to treatment and prevention of fatty acid deficiencies Download PDF

Info

Publication number
AU2022406916A1
AU2022406916A1 AU2022406916A AU2022406916A AU2022406916A1 AU 2022406916 A1 AU2022406916 A1 AU 2022406916A1 AU 2022406916 A AU2022406916 A AU 2022406916A AU 2022406916 A AU2022406916 A AU 2022406916A AU 2022406916 A1 AU2022406916 A1 AU 2022406916A1
Authority
AU
Australia
Prior art keywords
composition
omega
fatty acids
aspects
dha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022406916A
Other languages
English (en)
Inventor
Scott FLIGOR
Kathleen GURA
Mark Puder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of AU2022406916A1 publication Critical patent/AU2022406916A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2022406916A 2021-12-09 2022-12-07 Methods and compositions relating to treatment and prevention of fatty acid deficiencies Pending AU2022406916A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163287564P 2021-12-09 2021-12-09
US63/287,564 2021-12-09
PCT/US2022/052076 WO2023107527A1 (en) 2021-12-09 2022-12-07 Methods and compositions relating to treatment and prevention of fatty acid deficiencies

Publications (1)

Publication Number Publication Date
AU2022406916A1 true AU2022406916A1 (en) 2024-07-04

Family

ID=86731142

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022406916A Pending AU2022406916A1 (en) 2021-12-09 2022-12-07 Methods and compositions relating to treatment and prevention of fatty acid deficiencies

Country Status (6)

Country Link
EP (1) EP4444110A4 (https=)
JP (1) JP2024545117A (https=)
CN (1) CN118678891A (https=)
AU (1) AU2022406916A1 (https=)
CA (1) CA3239875A1 (https=)
WO (1) WO2023107527A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026060283A1 (en) * 2024-09-13 2026-03-19 Baxter International Inc. Lipid emulsions for parenteral nutrition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027991A2 (en) * 2006-08-29 2008-03-06 Martek Biosciences Corporation USE OF DPA(n-6) OILS IN INFANT FORMULA
WO2016040570A2 (en) * 2014-09-12 2016-03-17 Children's Medical Center Corporation Dietary emulsion formulations and methods for using the same

Also Published As

Publication number Publication date
EP4444110A4 (en) 2025-05-14
CN118678891A (zh) 2024-09-20
JP2024545117A (ja) 2024-12-05
CA3239875A1 (en) 2023-06-15
WO2023107527A1 (en) 2023-06-15
EP4444110A1 (en) 2024-10-16

Similar Documents

Publication Publication Date Title
US8951550B2 (en) Dietary formulations and methods for treatment of inflammation and other disorders
CN102088978B (zh) 血脂异常症的改善或治疗药
US20220226238A1 (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
NZ503666A (en) Composition suitable for enteral administration to counter the effects of lack of absorption due to Crohn's disease or other lipid maladaptive disease
JP2021526510A (ja) Ｇｐｃを含有する非経口栄養のための脂質エマルション
CN105394182A (zh) 一种具有降血糖功效及促进心脑血管健康的营养包
US20090099261A1 (en) Omega-3 mixtures
EP4444110A1 (en) Methods and compositions relating to treatment and prevention of fatty acid deficiencies
US20250009657A1 (en) Lipid emulsions for parenteral nutrition
JP4394174B2 (ja) 炎症性腸疾患治療剤
US20250009699A1 (en) Lipid emulsions for parenteral nutrition
JP2010229099A (ja) 脂質異常症の改善または治療薬
WO2020259493A1 (en) Compositions and methods for the prevention or treatment, or dietary management of nafld
RU2783166C2 (ru) Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты
RU2783166C9 (ru) Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты
WO2013005834A1 (ja) 高純度ｅｐａを含有する抗肥満剤
HK40023767A (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
HK40023767B (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
BR112020002638B1 (pt) Métodos e composições relativas a emulsões compreendendo óleo de peixe e/ou ácidos graxos ômega-3
HK40022806A (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
WO2026060283A1 (en) Lipid emulsions for parenteral nutrition